$SNX

HUME RICHARD T sold $8K of SNX

HUME RICHARD T sold 28 shares of TD SYNNEX CORP (SNX) at $276.50 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HUME RICHARD T
Published Jun 3, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNX
Neutral
high confidence
Mentioned
$SNX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNXNeutralLow
01

Why it matters

The disclosure provides transparency on insider activity but does not, by itself, indicate a fundamental change because it is explicitly under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the filing for completeness, but it is unlikely to drive a material repricing without corroborating fundamental news.

03

What to watch

The sale size is small relative to typical insider holdings, and the 10b5-1 structure limits inference about near-term expectations.

Relevance 6/10Novelty 3/10Timing: Filed June 3; sale executed June 2 under a 10b5-1 plan

Background

This is an SEC Form 4 insider transaction disclosure (director selling the company’s shares).

Company-level read

Ticker impact

$SNXNeutralHigh confidence
Context

TD SYNNEX director Hume Richard T sold 28 shares in an open-market transaction at $276.50/share under a 10b5-1 plan.

Expected impact

Minimal near-term impact; any reaction likely limited unless paired with other company-specific catalysts.

Evidence & confidence

The filing is a small, director-level open-market sale explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive value for near-term fundamentals.

Market effects

No clear sector read-through from a single, pre-arranged director sale.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with periods of weaker outlook; monitor for additional filings.

Key entities

  • TD SYNNEX CORP

    Company whose director insider sale was reported on SEC Form 4.

  • HUME RICHARD T

    Director who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

$SNXHigh

TD SYNNEX CORP (SNX): Results of Operations and Financial Condition

TD SYNNEX CORP (SNX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-fy26q2pressrelease.htm EX-99.1 Document Exhibit 99.1 TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results • Revenue of $19.6 billion, an increase of 31.0% year over year, 29.1% in constant currency (1) , and significantly above the high end of our outlook.